KYNTRA Bio director granted 7,000 stock options
KYNTRA BIO, INC. director Ho Maykin received a grant of stock options covering 7,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
KYNTRA BIO, INC. director Ho Maykin received a grant of stock options covering 7,000 shares of common stock. The options have an exercise price of $7.13 per share and expire on June 11, 2036. They vest in four equal quarterly installments from the grant date, and this filing shows 7,000 options held directly after the award.
Insider Trade Summary
Grant/Award: 7,000 shares
Grant/Award
1 txn
Insider
Ho Maykin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 7,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option shall vest in four equal quarterly installments measured from the date of grant.
Key Figures
Options granted: 7,000 options
Exercise price: $7.13 per share
Expiration date: June 11, 2036
+2 more
5 metrics
Options granted
7,000 options
Stock Option (Right to Buy) grant to director Ho Maykin
Exercise price
$7.13 per share
Exercise price of stock options on common stock
Expiration date
June 11, 2036
Option term endpoint for 7,000 granted options
Shares underlying options
7,000 shares
Underlying common stock covered by the option grant
Post-transaction derivative holdings
7,000 options
Total options held directly after this grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"Security title is listed as "Stock Option (Right to Buy)" for 7,000 shares."
exercise price financial
"The conversion or exercise price of the options is reported as 7.1300 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to the option shall vest in four equal quarterly installments from the grant date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The options carry an expiration date of 2036-06-11 for the granted award."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KYNTRA BIO (KYNB) report for Ho Maykin?
KYNTRA BIO reported that director Ho Maykin received a grant of stock options for 7,000 shares of common stock. These options are a compensation award, not an open-market purchase, and give the right to buy shares at a fixed exercise price in the future.
How many KYNTRA BIO (KYNB) stock options were granted and at what price?
Ho Maykin was granted 7,000 stock options, each with an exercise price of $7.13 per share. The grant price itself is $0.00, reflecting a typical equity compensation award, with value realized only if the stock trades above the exercise price later.
When do Ho Maykin’s KYNTRA BIO (KYNB) stock options vest?
The 7,000 stock options vest in four equal quarterly installments starting from the grant date. This means 25% of the options become exercisable every quarter over a one-year period, aligning ongoing vesting with continued service as a director at the company.
When do the granted KYNTRA BIO (KYNB) stock options expire?
The granted stock options expire on June 11, 2036, giving Ho Maykin roughly a decade to exercise them after vesting. If they are not exercised by the expiration date, the right to purchase the underlying 7,000 common shares will lapse entirely.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates